Patents by Inventor Alexander Godfrey

Alexander Godfrey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200374137
    Abstract: Systems, methods, and storage media, for enforcing transaction permissions delegation in a computing environment are disclosed. Exemplary implementations may: receive a permissions request, from a requesting computing system for a permissions certificate; transmit a login request to a user computing system associated with a user; receive an acceptance from the user in response to the login request; generate a permissions certificate data structure in response to the acceptance; and return the permissions certificate to the requesting computing system whereby the requesting computing system will be permitted to accomplish the transaction with a transacting party in place of the issuer computing system based on possession of the permissions certificate paired with a cryptographic signature based on a private cryptographic key associated with the requesting computing system.
    Type: Application
    Filed: May 24, 2019
    Publication date: November 26, 2020
    Inventor: Wilfred James Alexander Godfrey
  • Publication number: 20200105281
    Abstract: Captured vocals may be automatically transformed using advanced digital signal processing techniques that provide captivating applications, and even purpose-built devices, in which mere novice user-musicians may generate, audibly render and share musical performances. In some cases, the automated transformations allow spoken vocals to be segmented, arranged, temporally aligned with a target rhythm, meter or accompanying backing tracks and pitch corrected in accord with a score or note sequence. Speech-to-song music applications are one such example. In some cases, spoken vocals may be transformed in accord with musical genres such as rap using automated segmentation and temporal alignment techniques, often without pitch correction. Such applications, which may employ different signal processing and different automated transformations, may nonetheless be understood as speech-to-rap variations on the theme.
    Type: Application
    Filed: May 13, 2019
    Publication date: April 2, 2020
    Inventors: Parag Chordia, Mark Godfrey, Alexander Rae, Prerna Gupta, Perry R. Cook
  • Patent number: 10290307
    Abstract: Captured vocals may be automatically transformed using advanced digital signal processing techniques that provide captivating applications, and even purpose-built devices, in which mere novice user-musicians may generate, audibly render and share musical performances. In some cases, the automated transformations allow spoken vocals to be segmented, arranged, temporally aligned with a target rhythm, meter or accompanying backing tracks and pitch corrected in accord with a score or note sequence. Speech-to-song music applications are one such example. In some cases, spoken vocals may be transformed in accord with musical genres such as rap using automated segmentation and temporal alignment techniques, often without pitch correction. Such applications, which may employ different signal processing and different automated transformations, may nonetheless be understood as speech-to-rap variations on the theme.
    Type: Grant
    Filed: May 26, 2017
    Date of Patent: May 14, 2019
    Assignee: SMULE, INC.
    Inventors: Parag Chordia, Mark Godfrey, Alexander Rae, Prerna Gupta, Perry R. Cook
  • Publication number: 20060058295
    Abstract: The current invention relates to compounds of the formula: (Ia) and the pharmaceutically acceptable salts thereof and their use as TGF-beta signal transduction inhibitors for treating cancer and other diseases in a patient in need thereof by administration of said compounds.
    Type: Application
    Filed: November 24, 2003
    Publication date: March 16, 2006
    Applicant: Eli Lilly and Company
    Inventors: Douglas Beight, Timothy Burkholder, Todd Decollo, Alexander Godfrey, Charles Heap, Chi-Hsin King, Hong-Yu Li, William McMillen, Jason Sawyer, Yan Wang, Clive Diefenbacher, Thomas Engler, Sushant Malhotra, Sreenivasa Mundla
  • Publication number: 20060009464
    Abstract: A series of aryl piperazine compounds are effective pharmaceuticals for the treatment of conditions related to or affected by the serotonin 1A receptor; the compounds are particularly effective antagonists at that receptor, and are particularly useful for alleviating the symptoms of nicotine and tobacco withdrawal.
    Type: Application
    Filed: September 13, 2005
    Publication date: January 12, 2006
    Inventors: Alexander Godfrey, Daniel Kohlman, John O'Toole, Yao-Chang Xu, Tony Zhang, Jeffrey McKelvy
  • Publication number: 20050282817
    Abstract: A series of aryl piperazine compounds are effective pharmaceuticals for the treatment of conditions related to or affected by the serotonin 1A receptor; the compounds are particularly effective antagonists at that receptor, and are particularly useful for alleviating the symptoms of nicotine and tobacco withdrawal.
    Type: Application
    Filed: July 19, 2005
    Publication date: December 22, 2005
    Inventors: Alexander Godfrey, Daniel Kohlman, John O'Toole, Yao-Chang Xu, Tony Zhang
  • Publication number: 20050250825
    Abstract: Compounds represented by the following structural formula (I), and pharmaceutically acceptable salts, solvates and hydrates thereof, wherein R1 is an unsubstituted or substituted aryl, heteroaryl, cycloalkyl, aryl-alkyl, heteroaryl-alkyl or cycloalkyl-alkyl, R2 is H, alkyl or haloalkyl, the polymethylene chain (H), is saturated or may contain a carbon-carbon double bond, while n is 2, 3, 4, W is O or S, Y is an unsubstituted phenylene, naphthylene or 1, 2, 3, 4 tetrahydronaphthylene, R3 is H, alkyl or haloalkyl, R4 is H, alkyl, haloalkyl or a substituted or unsubstituted benzyl, are useful for modulating a peroxisome proliferator activated receptor, particularly in the treatment of diabetes mellitus.
    Type: Application
    Filed: July 14, 2005
    Publication date: November 10, 2005
    Inventors: Dawn Brooks, Scott Conner, Samuel Dominianni, Alexander Godfrey, Lynn Gossett, Christopher Rito, Allie Tripp, Alan Warshawsky, Leonard Winneroski, Guoxin Zhu
  • Publication number: 20050245584
    Abstract: Compounds represented by the following structural formula (I), and pharmaceutically acceptable salts, solvates and hydrates thereof, wherein: n is 2, 3, or 4 and W is CH2, CH(OH), C(O) or O; R1 is an unsubstituted or substituted aryl, heteroaryl, cycloalkyl, heterocycloalkyl, aryl-alkyl, heteroaryl-alkyl, cycloalkyl-alkyl, or t-butyl; R2 is H, alkyl, haloalkyl or phenyl; Y is an unsubstituted or substituted thiophen-2,5-diyl or phenylene; R3 is alkyl or haloalkyl; R4 is a substituted or unsubstituted phenyl, naphthyl, 1,2,3,4-tetrahydronaphthyl, quinolyl, pyridyl or benzo[1,3]dioxol-5-yl group; and R5 is H, alkyl, or aminoalkyl; are useful for modulating a peroxisome proliferator activated receptor, particularly in the treatment of diabetes mellitus.
    Type: Application
    Filed: February 9, 2005
    Publication date: November 3, 2005
    Inventors: Dawn Brooks, Alexander Godfrey, Sarah Jones, James McCarthy, Christopher Rito, Leonard Winneroski, Yanping Xu